期刊文献+

非霍奇金淋巴瘤患者外周血CD4^+CD25^highCD127^low调节性T细胞水平与其临床特点的关系 被引量:3

Correlation between peripheral blood CD4+CD25highCD127low regulatory T cell and clinical characteristics of patients with non-Hodgkin's lymphom
原文传递
导出
摘要 目的探讨外周血CD4+CD25highCD127low调节性T细胞(Treg细胞)水平与非霍奇金淋巴瘤(NHL)的关系。方法采用流式细胞术检测123例初治NHL患者、41名健康成年人外周血c功c础}CD笛,IIreg水平,并分析其与临床因素的关系。结果健康成年人外周血CD4+CD25highCD127lowTreg水平中位数为5,0%(四分位数间距为2.7%),初诊NHL患者中位数为7.2%(四分位数间距为3.8%),两者之间差异有统计学意义(Z=~2.816,P=0.001)。初诊NHL患者外周血Treg水平在男性患者中中位数为7.2%(四分位数间距为7.4%),在女性患者中中位数为6.1%(四分位数间距为3.8%),差异有统计学意义(Z=-2.729,P=0.006);乳酸脱氢酶(LDH)增高组中位数为7.8%(四分位数间距为5.9%),LDH正常组中位数为7.0%(四分位数间距为3.3%),差异具有统计学意义(Z=-2.623,P:0.008);III~IV期患者中位数为7-3%(四分位数间距为5.3%),I一Ⅱ期患者中位数为5.9%(四分位数间距为3.7%),差异有统计学意义(Z=-2.057,P=0.04);而NHL患者在不同年龄、IPI评分、结外病变、体能状况、大包块、病理类型、B症状等之间外周血Treg水平差异无统计学意义(均P〉0.05)。结论NHL患者体内存在免疫抑制,在男性患者、LDH增高患者及分期为Ⅲ~Ⅳ期患者中CD4+CD25highCD127lowTreg水平明显增高。 Objective To explore the relationship between CD4+CD25highCD127low Treg level of peripheral blood and NHL.Methods The level of peripheral blood CD4+CD25highCD127low Treg of 123 newly diagnosed NHL D low and 41 healthy adults were test by flow cytometry.Results The average peripheral blood CD4+CD25highCD127low Treg level were 5.0 % (2.7 %) and 7.2 %(3.8 %) in healthy adults and newly diagnosed NHL patients, respectively. The difference between the two groups was statistically signifieant(Z = -2.816 P=0.001). The peripheral blood Treg level was significantly higher in the male NHL patients than that in the female (7.4% vs 6.1% ,Z= -2.729,P=0.006).The peripheral blood Treg level was significantly higher in elevated LDH patients than that in normal LDH patients(7.8% vs 7.0%,Z = - 2.623 P=0.008). The peripheral blood Treg level was significantly higher in stage III-IV patients than that in stage I -II patients (7.3% vs 5.9%,Z= -2.057 P=0.04). There was no significant relationship between peripheral blood Treg level and age, IPI score, extranodal involvement,performance status,bulky disease,pathologic subtype or B symptom (P 〉0.05). Conclusions NHL patients are in an immunosuppresive statue. Patients of male, with inreased LDH level or in stage III -IV have higher peripheral blood CD4+CD25highCD127low Treg level.
出处 《白血病.淋巴瘤》 CAS 2012年第4期218-220,224,共4页 Journal of Leukemia & Lymphoma
关键词 淋巴瘤 非霍奇金 T细胞 调节性 Lymphoma, non-Hodgkin T-lymphocytes, regulatory
  • 相关文献

参考文献7

二级参考文献100

  • 1刘陶文,陈煌基.肿瘤相关物质群(TSGF)联合检测的临床应用研究[J].华夏医学,2004,17(3):293-297. 被引量:8
  • 2刘莉,姚军霞,丁乾,黄士昂.非霍奇金淋巴瘤患者外周血CD4^+CD25^(high)调节性T细胞研究[J].中国实验血液学杂志,2006,14(1):119-122. 被引量:30
  • 3潘启超 胥彬.我国实体肿瘤客观疗效评定标准[A]..肿瘤药理学及化学治疗学[C].广州:广东高教出版社,1989.431.
  • 4Shipp M,Harringtin D,Anderson J,et al.A predictive model for aggresivelymphoma:the intermational NHL prognostic factors project[J].N Engl Med.1993;329:987.
  • 5Gatti RA, Good RA. Occurrence of malignancy in immunodeficiency diseases. A literature review [J]. Cancer, 1971,28( 1 ) : 89-98.
  • 6Hoshida Y, Tsuknma H, Yasunaga Y, et al. Cancer risk after renal transplantation in Japan [J]. Int J Cancer, 1997,71 (4) :517-520.
  • 7Sakaguchi S, Sakaguchi N, Shimizu J, et al. Immunologic tolerance maintained by CD25" CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance [J]. Immunol Rev, 2001,182: 18-32.
  • 8Valencia X, Lipsky PE. CD4^+CD25^+FoxP3^+ regulatory T cells in autoimmune diseases [J]. Nat Clin Pract Rheumatol, 2007,3 ( 11 ) : 619-626.
  • 9Wolf AM, Wolf D, Steurer M, et al. Increase of regulatory T cells in the peripheral blood of cancer patients [J].Clin Cancer Res, 2003,9 (2) : 606-612.
  • 10Sakaguchi S, Sakaguchi N, Asano M, et al. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases[J].J Immunol, 1995,155(3) : 1151-1164.

共引文献47

同被引文献29

  • 1王德林,朱军.恶性淋巴瘤的血清肿瘤标志[J].白血病.淋巴瘤,2005,14(6):335-338. 被引量:8
  • 2刘莉,姚军霞,丁乾,黄士昂.非霍奇金淋巴瘤患者外周血CD4^+CD25^(high)调节性T细胞研究[J].中国实验血液学杂志,2006,14(1):119-122. 被引量:30
  • 3Au WY.Current management of nasal NK/T-cell lymphoma[J].Oncology,2010,24(4):352-358.
  • 4Kwong YL.The diagnosis and management ofextranodal NK/T-cell lymphoma,nasal-type and aggressive NK-cell leukemia[J].J Clin Exp Hematop,2011,51 (1):21-28.
  • 5Yamagami W,Susumu N,Tanaka H,et al.Immunofluorescencedetected infiltration of CD4-POXP3-regulatory T cells is relevant to the prognosis of patients with endometrial cancer[J].Int J Gynecol Cancer,2011,21 (9):1628-1634.
  • 6Xu D,Wang FS.Are non-traditional CD4(+)CD69(+)CD25(-) regulatory T cells involved in disease progression of human hepatocellular carcinoma?[J].J Gastroenterol Hepatol,2011,26(10):1469-1470.
  • 7Mittal S,Marshall NA,Duncan L,et al.Local and systemic induction of CD4+CD25+ regulation T-cell population by non-Hodgkin lymphoma[J].Blood,2008,111 (11):5359-5370.
  • 8Swerdlow SH,Campo E,Harris NL,et al.WHO Classification of tumours of haematopoietic and lymphoid tissues[M].Lyon:IARC Press,2008:14-15.
  • 9Sakaguchi S,Sakaguchi N,Asano M,et al.Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains(CD25).Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases[J].J Immunol,1995,155(3):1151-1164.
  • 10Wing K,Sakaguchi S.Regulatory T cells exert checks and balances on self tolerance and autoimmunity[J].Nat Immunol,2010,11(1):7-13.

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部